First Aid Triple Antibiotic with Pain Reliever Interactions
There are 100 drugs known to interact with First Aid Triple Antibiotic with Pain Reliever (bacitracin / lidocaine / neomycin / polymyxin b topical), along with 7 disease interactions. Of the total drug interactions, 2 are major, 91 are moderate, and 7 are minor.
- View all 100 medications that may interact with First Aid Triple Antibiotic with Pain Reliever
- View First Aid Triple Antibiotic with Pain Reliever disease interactions (7)
Most frequently checked interactions
View interaction reports for First Aid Triple Antibiotic with Pain Reliever (bacitracin / lidocaine / neomycin / polymyxin b topical) and the medicines listed below.
- 5-HTP (5-hydroxytryptophan)
- acetaminophen
- Adderall XR (amphetamine / dextroamphetamine)
- Airborne (multivitamin with minerals)
- Airborne Gummies (multivitamin with minerals)
- albuterol
- Alcohol (contained in alcoholic beverages) (ethanol)
- alprazolam
- amiodarone
- amlodipine
- amoxicillin
- amphetamine / dextroamphetamine
- ashwaganda
- Benadryl (diphenhydramine)
- cefdinir
- clobetasol topical
- CoQ10 (ubiquinone)
- diazepam
- famotidine
- ibuprofen
- ketoconazole topical
- losartan
- milk thistle
- Mucinex (guaifenesin)
- nystatin topical
- omeprazole
- Rolaids Advanced (calcium carbonate / magnesium hydroxide / simethicone)
- turmeric
- Vitamin D3 (cholecalciferol)
- Vitamin K2 (menaquinone)
First Aid Triple Antibiotic with Pain Reliever disease interactions
There are 7 disease interactions with First Aid Triple Antibiotic with Pain Reliever (bacitracin / lidocaine / neomycin / polymyxin b topical) which include:
- teething pain
- cardiovascular dysfunction
- hepatic dysfunction
- renal dysfunction
- seizures
- perforated tympanic membrane
- burns
Report options
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.